What is the impact of thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty?
A study from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial found that baseline thrombocytopenia can have a significant impact on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty.